Expanding role of lenalidomide in hematologic malignancies

Nilanjan Ghosh, Michael R Grunwald, Omotayo Fasan, Manisha Bhutani Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA Abstract: Lenalidomide is an immunomodulatory agent that has been approved by the US Food and Drug Administration for treatment of multiple myeloma, deletion 5...

Full description

Bibliographic Details
Main Authors: Ghosh N, Grunwald MR, Fasan O, Bhutani M
Format: Article
Language:English
Published: Dove Medical Press 2015-05-01
Series:Cancer Management and Research
Online Access:http://www.dovepress.com/expanding-role-of-lenalidomide-in-hematologic-malignancies-peer-reviewed-article-CMAR